4CPS-009 Duration of dual antiplatelet therapy in coronary artery disease: is pharmacist intervention necessary to improve patient safety?

Background and importanceAccording to the 2017 updated guidelines from the European Society of Cardiology on dual antiplatelet therapy (DAPT), the optimal duration of DAPT remains a controversial topic. The decision must be dynamic and re-evaluated during the course of treatment. Hence it is essenti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A51-A51
Hauptverfasser:	Revuelta Amallo, A, Alonso Diez, M, Alvarez Lavin, M, Ruiz De Velasco Artaza, E, Fernandez Uria, J, Aguirrezabal Arredondo, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Cardiovascular disease Heart attacks Long term Patient safety Stents Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!